Title:
FIXED DOSE FORMULATIONS
Document Type and Number:
Japanese Patent JP2023022224
Kind Code:
A
Abstract:
To provide stable and effective pharmaceutical compositions that allow formulation of bempedoic acid and ezetimibe that have improved, desirable pharmacokinetic and bulk physical properties.SOLUTION: A pharmaceutical composition comprises: bempedoic acid admixed with a lubricant selected from the group consisting of colloidal silicon dioxide, sodium stearyl fumarate, and magnesium stearate; ezetimibe; and a pharmaceutically acceptable excipient. The formulations herein provide pharmaceutical compositions having excellent stability and release properties for both drug products. These improved formulations are useful in the treatment and prevention of cardiovascular disease.SELECTED DRAWING: None
More Like This:
Inventors:
Abdernasale, Mohamed
Pirga on Cal, Plativa, Es.
Gandhi, Anilkumar S.
Pirga on Cal, Plativa, Es.
Gandhi, Anilkumar S.
Application Number:
JP2022191728A
Publication Date:
February 14, 2023
Filing Date:
November 30, 2022
Export Citation:
Assignee:
Esperion Therapeutics, Inc.
International Classes:
A61K31/194; A61K9/14; A61K9/16; A61K9/20; A61K9/24; A61K31/397; A61K47/04; A61K47/12; A61K47/14; A61K47/20; A61K47/26; A61K47/32; A61K47/36; A61K47/38; A61P3/06; A61P9/00; A61P43/00
Attorney, Agent or Firm:
Patent Attorney Corporation Hiraki International Patent Office
Previous Patent: fuel injector
Next Patent: RIP1 inhibitor compounds and methods for making and using same
Next Patent: RIP1 inhibitor compounds and methods for making and using same